Ipamorelin CJC-1295 No DAC Blend
+99% Purity cGMP Certified COA Every Batch
Blend Blend

Ipamorelin CJC-1295 No DAC Blend

4.9 (47 reviews)

Stackpure provides Ipamorelin CJC-1295 No DAC Blend for GH axis optimisation, body composition, anti-aging, and recovery acceleration research. This research-grade peptide blend is the gold-standard GHRP+GHRH combination: Ipamorelin (selective GH pulse) + CJC-1295 No-DAC (amplified GHRH signal) for synergistic, physiologically pulsatile GH release research. Produced to +99% purity (HPLC verified), cGMP-certified, with a Certificate of Analysis available every batch.

For in vitro research use only. Not for human consumption. Not approved by the FDA. Not a drug, medicine, or supplement.

In Stock · Ships 1–3 days
$29.98
USD · Research pricing
1
Build a Stack
Format Blend
Purity +99% (HPLC verified)
Certification cGMP-certified facility
Certificate COA every batch, see testing standards on the Lab Testing page →
Certificate of Analysis, every batch
Product Ipamorelin CJC-1295 No DAC Blend
Analytical Method HPLC / ESI-MS
Purity Standard +99%
Testing Party Independent third-party lab

Your batch's actual Certificate of Analysis is available on request with your order and batch number, usually within 24 hours. Full testing standards on the Lab Testing page.

Ipamorelin CJC-1295 No DAC Peptide Blend is a research-grade peptide blend supplied by Stackpure for laboratory investigation. Ipamorelin CJC-1295 No DAC is studied in the context of tissue repair, wound healing, and musculoskeletal recovery. Each unit is manufactured in a cGMP-certified facility and verified to +99% purity by HPLC analysis before dispatch.

What Is Ipamorelin CJC-1295 No DAC?

Ipamorelin CJC-1295 No DAC is a compound that has attracted significant interest in preclinical research examining tissue repair, wound healing, and musculoskeletal recovery. Scientists investigating Ipamorelin CJC-1295 No DAC have worked to characterise its mechanisms, receptor interactions, and downstream biological effects across multiple in vitro and animal model systems.

Stackpure provides Ipamorelin CJC-1295 No DAC peptide blend for researchers requiring verified, traceable material. This blend combines complementary compounds to support multi-mechanism research investigations. Researchers may also be interested in Ipamorelin CJC-1295 No DAC Nasal Spray, which provides the same compound in an alternative format.

Ipamorelin CJC-1295 No DAC Peptide Blend Research Applications

Preclinical studies involving Ipamorelin CJC-1295 No DAC peptide blend have explored the following areas:

  • Tissue regeneration: Studies have examined the role of this compound in accelerating repair of damaged connective tissue, tendons, and ligaments.
  • Wound healing: Preclinical models have investigated angiogenic and fibroblast-stimulating properties relevant to dermal and mucosal wound repair.
  • Musculoskeletal support: Research has explored protective and regenerative effects on muscle, bone, and cartilage under injury conditions.

These directions reflect the broad scientific interest in Ipamorelin CJC-1295 No DAC and the growing body of literature examining its potential applications in research contexts.

Stackpure Ipamorelin CJC-1295 No DAC Peptide Blend Quality Standards

Every Ipamorelin CJC-1295 No DAC peptide blend supplied by Stackpure is held to rigorous analytical standards. Researchers choosing Stackpure peptide blend receive material that has been independently verified for identity, purity, and potency. Quality documentation includes a Certificate of Analysis (COA) for every production batch, providing full analytical transparency.

  • Purity: +99% by HPLC analysis
  • Facility: cGMP-certified manufacturing
  • Testing: Identity, purity, and potency verified per batch
  • Documentation: COA available for every order

This analytical rigour ensures that researchers working with Stackpure Ipamorelin CJC-1295 No DAC peptide blend can maintain experimental consistency and reproducibility across studies.

Research Use Disclaimer

Independent Lab Verification

Stackpure works with independent, accredited third-party laboratories, including Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), to verify compound identity and purity. A Certificate of Analysis is included with every order.

Ipamorelin CJC-1295 No DAC Peptide Blend from Stackpure is supplied strictly for in vitro research and laboratory purposes. This material is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any condition. All research involving Ipamorelin CJC-1295 No DAC peptide blend must be conducted in accordance with applicable institutional, ethical, and regulatory guidelines. For research use only.

Working with a blend

  • Two or more compounds are supplied in a single vial, so one preparation covers the whole combination.
  • The ratio between the compounds is fixed by the blend, which is what makes it repeatable across runs.
  • Reconstitute and store as you would the individual lyophilized compounds.

Other formats of Ipamorelin CJC-1295 No DAC

FormatPrice (USD)
Ipamorelin CJC-1295 No DAC Pre-Mixed Peptide $33.34 View
Ipamorelin CJC-1295 No DAC Nasal Spray $39.67 View

Research Questions

What is Ipamorelin CJC-1295 No DAC Blend used for in research?

this blend is a research-grade peptide blend studied for GH axis optimisation, body composition, anti-aging, and recovery acceleration research. It acts as the gold-standard GHRP+GHRH combination: Ipamorelin (selective GH pulse) + CJC-1295 No-DAC (amplified GHRH signal) for synergistic, physiologically pulsatile GH release research. All findings are from pre-clinical in vitro and animal studies; it is not approved for human use.

How does Ipamorelin CJC-1295 No DAC Blend work?

this blend is the gold-standard GHRP+GHRH combination: Ipamorelin (selective GH pulse) + CJC-1295 No-DAC (amplified GHRH signal) for synergistic, physiologically pulsatile GH release research. This mechanism has been characterised in multiple pre-clinical studies, with particular focus on GH axis optimisation outcomes.

What research dosage is used for Ipamorelin CJC-1295 No DAC Blend?

Both compounds at 100–300 mcg per injection, administered 1–3 times daily in research protocols. All dosage information is from pre-clinical or research contexts only. this blend is sold exclusively for research use and is not approved for human consumption.

How does Ipamorelin CJC-1295 No DAC Blend compare to related research compounds?

this blend is frequently studied alongside Ipamorelin alone, or GHRP-6 + CJC-1295 combinations for selectivity comparison. Its GHRP/GHRH combination classification distinguishes its mechanism from these alternatives, making it suitable for pathway-specific research protocols.

Where can I buy Ipamorelin CJC-1295 No DAC Blend for research purposes?

Stackpure supplies this blend as a research-grade peptide blend with +99% purity (HPLC verified), cGMP certification, and a Certificate of Analysis. Orders ship to the US, UK, Canada, and Australia. It is sold for in vitro research use only.

What does the Certificate of Analysis verify for Ipamorelin CJC-1295 No DAC Blend?

A Certificate of Analysis (COA) reports identity (confirming the compound is what it's labeled as, via HPLC-UV/VIS matched against a reference standard) and assay/content (the measured purity percentage). this blend is tested through independent third-party laboratory analysis, including work performed by Vanguard Laboratory (ISO 17025:2017-accredited, A2LA Certificate #6377.01.01), which is what verifies a batch matches its labeled specification rather than relying on a purity claim alone.